Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,847 | -1,580 | -7,792 | -5,805 | -4,111 |
| Accounts receivable | -1,330 | -779 | -48 | -609 | -399 |
| Other Working Capital | -1,183 | -1,378 | 1,050 | 590 | 385 |
| Other Operating Activity | 1,960 | 1,158 | 1,806 | 1,945 | 1,288 |
| Operating Cash Flow | $-3,400 | $-2,579 | $-4,985 | $-3,879 | $-2,837 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,265 | 7,969 | N/A | N/A | N/A |
| Other Financing Activity | -426 | -426 | -119 | 0 | 0 |
| Financing Cash Flow | $7,838 | $7,543 | $-119 | $N/A | $N/A |
| Beginning Cash Position | 4,739 | 4,739 | 9,844 | 9,844 | 9,844 |
| End Cash Position | 9,178 | 9,703 | 4,739 | 5,965 | 7,006 |
| Net Cash Flow | $4,438 | $4,963 | $-5,104 | $-3,879 | $-2,837 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,400 | -2,579 | -4,985 | -3,879 | -2,837 |
| Free Cash Flow | -3,400 | -2,579 | -4,985 | -3,879 | -2,837 |